Study for Prevention of Cervical Cancer in Spain

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

October 31, 2026

Conditions
Cervical Cancer ScreeningHPV Vaccination
Interventions
BIOLOGICAL

Evaluate the effectiveness of current Human Papillomavirus (HPV) vaccination and screening programs in reducing cervical cancer incidence in Spain.

Data will be collected from existing medical records and supplemented with a specific questionnaire administered to the participating patients.

All Listed Sponsors
lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER